n.zielinski

TL2 Moderator · Nairobi

Contributes reviews on supplier material. Based in Nairobi.

Joined 21 May 2025 · last posted 18h

81 posts, newest first. Showing up to 150.

Stability of BPC-157 in solution: what has been measured — one year on Replied, post #99 · Compounds › Repair & healing peptides · 27 Jul 2026 · 11 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
Coming back to: A structured critique template this community uses Replied, post #69 · Evidence › Study critique · 26 Jul 2026 · 4 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
Transit times by route, from a logged dataset Replied, post #29 · Sourcing › Logistics · 23 Jul 2026 · 7 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
What a certificate commits its issuer to Replied, post #80 · Analytics › COA interpretation · 22 Jul 2026 · 21 likes On post #76 — agreed on the reasoning, with one qualification. Purity and content are different measurements: purity tells you what proportion of the detected material…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #18 · Clinical › Prescriber conversations · 19 Jul 2026 · 1 like Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
Here for the analytics and not much else Replied, post #52 · Lounge › Introductions · 18 Jul 2026 · 23 likes Coming back to post #50, because the follow-up matters more than the original answer. Privacy: share only what you are comfortable making permanent and public. An…
What a reversed-phase purity number actually is Replied, post #65 · Analytics › HPLC & UHPLC · 17 Jul 2026 · 6 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #4 · Compounds › Oral incretins · 17 Jul 2026 · 22 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #79 · Analytics › Home & field testing · 17 Jul 2026 · 3 likes I read post #77 twice before replying, because I had assumed the opposite. What physical quantity does the device measure? A colorimetric or lateral-flow method…
Priming a pen and whether the primed volume is wasted Replied, post #9 · Devices › Pens & autoinjectors · 17 Jul 2026 · 31 likes On post #5 — agreed on the reasoning, with one qualification. Priming: most pens require priming before the first use (injecting a small amount to fill the needle and…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #125 · Practice › Reconstitution · 15 Jul 2026 · 18 likes This follows post #122 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #19 · Start Here › How to Ask · 13 Jul 2026 · 20 likes Coming back to post #17, because the follow-up matters more than the original answer. Five questions in one post gets you one answer: the easiest one, usually not the…
CJC-1295 with and without DAC: what the modification does Replied, post #100 · Compounds › Secretagogues & GH axis · 2 Jul 2026 · 0 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
Talking to a therapist about this specifically Replied, post #15 · Wellbeing › Mental health · 23 Jun 2026 · 10 likes Coming back to post #13, because the follow-up matters more than the original answer. Substance use: if someone has a history of substance use, appetite suppression and…
A pooled estimate that changed when one trial was added Replied, post #8 · marked as the solution · Evidence › Meta-analyses · 10 Jun 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
A site rotation scheme that is easy enough to actually follow Replied, post #74 · Practice › Administration · 28 May 2026 · 3 likes post #73 answers the question as asked. The question underneath it is different. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #120 · Practice › Storage & stability · 22 May 2026 · 0 likes post #119 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Revisiting: Patterns that reliably precede a problem, documented Replied, post #2 · Sourcing › Red flags · 18 May 2026 · 0 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #26 · Analytics › COA interpretation · 2 May 2026 · 18 likes post #25 is right about the mechanism and I think understates the practical bit. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A…
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #13 · Pharmacology › Pharmacokinetics · 11 Apr 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Spike-and-recover accuracy for a peptide assay Replied, post #67 · Analytics › Method validation · 9 Apr 2026 · 5 likes post #66 answers the question as asked. The question underneath it is different. Linearity: the detector response is proportional to compound concentration across the…
Sample handling between despatch and injection Replied, post #11 · Analytics › Method validation · 1 Apr 2026 · 10 likes post #10 is right about the mechanism and I think understates the practical bit. Forced degradation studies: deliberately stress the material with acid, base, oxidant,…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #85 · Pharmacology › Pharmacokinetics · 27 Mar 2026 · 15 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #35 · Sourcing › Vendor reports · 14 Mar 2026 · 6 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
[2026 update] Composite endpoints and the component doing the work Replied, post #21 · Evidence › Trials · 6 Mar 2026 · 13 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
The lowest dose that does anything: is that a real question? Replied, post #56 · Practice › Dosing & titration · 5 Mar 2026 · 19 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
Rotating between abdomen, thigh and upper arm: absorption differences Replied, post #2 · Practice › Administration · 19 Feb 2026 · 3 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
Heterogeneity as information rather than as a nuisance Replied, post #92 · Evidence › Meta-analyses · 6 Feb 2026 · 9 likes This follows post #89 rather than contradicting it. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #82 · Access › International · 30 Jan 2026 · 12 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #13 · Clinical › Special populations · 21 Jan 2026 · 3 likes Picking up post #10: that is the part I would want checked first. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #80 · Practice › Side effects · 20 Jan 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #7 · Practice › Side effects · 12 Jan 2026 · 13 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #46 · Regional › UK & Ireland · 7 Jan 2026 · 27 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
Reverse causation in a cohort study of weight and outcome Replied, post #7 · Evidence › Study critique · 29 Dec 2025 · 0 likes post #6 answers the question as asked. The question underneath it is different. Confounding: in observational data, is there a third variable that explains the apparent…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #14 · Compounds › Oral incretins · 19 Dec 2025 · 21 likes This follows post #11 rather than contradicting it. Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #75 · Compounds › Oral incretins · 18 Dec 2025 · 7 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
Gastro-oesophageal reflux: improving or worsening? Replied, post #3 · Clinical › Comorbidities · 5 Dec 2025 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #20 · Evidence › Trials · 1 Dec 2025 · 2 likes This follows post #17 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #9 · Compounds › Tirzepatide · 1 Dec 2025 · 29 likes post #8 answers the question as asked. The question underneath it is different. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #37 · Compounds › Oral incretins · 9 Nov 2025 · 1 like post #36 is right about the mechanism and I think understates the practical bit. Oral bioavailability is variable between people. Some people absorb well; others absorb…
Reconciling a supplier certificate with an independent result Replied, post #21 · Sourcing › Vendor reports · 3 Nov 2025 · 27 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #128 · Compounds › Tirzepatide · 24 Oct 2025 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
Sleep tracking data and its considerable limitations Replied, post #69 · Wellbeing › Sleep · 23 Oct 2025 · 3 likes Coming back to post #67, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Research-use-only labelling: what it means and what it does not Replied, post #48 · Sourcing › Regulatory · 20 Oct 2025 · 30 likes Coming back to post #46, because the follow-up matters more than the original answer. Preclinical versus clinical: compounds with strong preclinical data can fail in…
Follow-up: Why appetite effects are mostly central Replied, post #66 · Pharmacology › Receptor biology · 13 Oct 2025 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #152 · Data & Tools › Datasets · 11 Sep 2025 · 12 likes post #151 answers the question as asked. The question underneath it is different. Privacy: if contributing data, only share data you are comfortable making permanent…
Managing an unplanned gap in supply — what changed since Replied, post #56 · Access › Shortages · 7 Sep 2025 · 19 likes post #55 answers the question as asked. The question underneath it is different. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
When a preprint is the best available evidence and we say so Replied, post #133 · Evidence › Preprints · 3 Sep 2025 · 2 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #103 · Compounds › Secretagogues & GH axis · 27 Aug 2025 · 0 likes post #102 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #39 · Compounds › Semaglutide · 9 Aug 2025 · 1 like The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #7 · Evidence › Journal club · 8 Aug 2025 · 1 like This follows post #4 rather than contradicting it. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint.…
A ten-fold dose error caught before injection — one year on Replied, post #119 · Devices › Syringes & needles · 4 Aug 2025 · 12 likes post #118 answers the question as asked. The question underneath it is different. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead…
The C-cell question: rodent findings and their human context Replied, post #44 · Compounds › Semaglutide · 28 Jul 2025 · 30 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
Thyroid function tests during substantial weight change Replied, post #13 · Clinical › Bloodwork · 25 Jul 2025 · 1 like Worth separating two things that post #9 runs together. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow…
Substitution between formats during a shortage Replied, post #25 · Access › Shortages · 19 Jul 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Regression to the mean in progress reports Replied, post #30 · Research Methods › Statistics · 8 Jul 2025 · 27 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
Thyroid function tests during substantial weight change Started this topic · Clinical › Bloodwork · 4 Jul 2025 · 0 likes Posting this under the heading it deserves: Thyroid function tests during substantial weight change Everything below is what sits behind that. General question, not a…
Subcutaneous absorption kinetics and site differences Replied, post #12 · Pharmacology › Pharmacokinetics · 1 Jul 2025 · 1 like Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
Repeatability versus intermediate precision Replied, post #93 · Analytics › Method validation · 29 Jun 2025 · 20 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #53 · Evidence › Trials · 15 Jun 2025 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Validating a calculator against hand arithmetic — what changed since Replied, post #130 · Data & Tools › Calculators · 12 Jun 2025 · 0 likes Picking up post #127: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
What a documentation review can and cannot tell you Replied, post #3 · marked as the solution · Sourcing › Independent verification · 10 Jun 2025 · 7 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #11 · Sourcing › Regulatory · 1 Jun 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #47 · Sourcing › Independent verification · 26 May 2025 · 8 likes I read post #45 twice before replying, because I had assumed the opposite. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted…
Storing a pen in use versus a pen unopened Replied, post #15 · Devices › Pens & autoinjectors · 21 May 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #42 · Evidence › Journal club · 20 May 2025 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
Coverage for the indication versus for the drug Replied, post #57 · Access › Insurance & coverage · 8 May 2025 · 13 likes post #56 is right about the mechanism and I think understates the practical bit. Documentation your clinician can provide: letters from clinicians describing why…
Carryover and the ghost peak from last week's standard Replied, post #32 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 14 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
Coming back to: An 18-month record including the parts that went badly Replied, post #34 · Outcomes › Progress reports · 1 Apr 2025 · 2 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
Counter-ion content and its effect on measured mass Replied, post #9 · marked as the solution · Analytics › Mass spectrometry · 1 Apr 2025 · 13 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #36 · Evidence › Meta-analyses · 1 Feb 2025 · 24 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
When "no data" is the complete and final answer Replied, post #75 · Compounds › Other compounds · 25 Jan 2025 · 24 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #54 · Analytics › COA interpretation · 25 Jan 2025 · 3 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #49 · Compounds › Semaglutide · 21 Dec 2024 · 12 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #131 · Compounds › Repair & healing peptides · 24 Nov 2024 · 22 likes This follows post #128 rather than contradicting it. What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised…
Requesting a page: what makes a good request — what changed since Replied, post #47 · Documentation › Wiki requests · 10 Oct 2024 · 5 likes Picking up post #44: that is the part I would want checked first. Correction requests: if you spot an error in a maintained page, note it here with the specific…
The C-cell question: rodent findings and their human context — what changed since Replied, post #41 · Compounds › Semaglutide · 8 Sep 2024 · 26 likes Worth separating two things that post #37 runs together. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
The mass-error checker and its intended scope Replied, post #120 · Data & Tools › Calculators · 13 Jul 2024 · 0 likes This follows post #117 rather than contradicting it. Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #106 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
The mass-error checker and its intended scope Replied, post #97 · Data & Tools › Calculators · 4 Jul 2024 · 22 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
How this community labels and discusses unrefereed work Replied, post #40 · Evidence › Preprints · 25 Jun 2024 · 0 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…